Philip Morris Aktie 3754629 / US7181721090
119.02
USD
0.65
USD
0.55%
05.10.2024
BTT
Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
---|---|---|---|---|---|---|
Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
Orderbuch | Analysen | |||||
Historisch |
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Philip Morris Dividenden Kalender
Datum | Name | Rendite * | Dividende | Währung |
---|---|---|---|---|
2023 | Philip Morris Inc. | 5.46 | 5.14 | USD |
2022 | Philip Morris Inc. | 4.98 | 5.04 | USD |
2021 | Philip Morris Inc. | 5.16 | 4.90 | USD |
2020 | Philip Morris Inc. | 5.73 | 4.74 | USD |
2019 | Philip Morris Inc. | 5.43 | 4.62 | USD |
2018 | Philip Morris Inc. | 6.73 | 4.49 | USD |
2017 | Philip Morris Inc. | 3.99 | 4.22 | USD |
2016 | Philip Morris Inc. | 4.50 | 4.12 | USD |
2015 | Philip Morris Inc. | 4.60 | 4.04 | USD |
2014 | Philip Morris Inc. | 4.76 | 3.88 | USD |
Gewinn je Aktie- Philip Morris
3.9 17 | 5.1 18 | 4.6 19 | 5.2 20 | 5.8 21 | 5.8 22 | 5.0 23 |
Umsatz je Aktie- Philip Morris
18.5 17 | 19.0 18 | 19.1 19 | 18.4 20 | 20.1 21 | 20.3 22 | 22.6 23 |
KGV- Philip Morris
27.2 17 | 13.1 18 | 18.5 19 | 16.1 20 | 16.3 21 | 17.4 22 | 18.8 23 |
Philip Morris Inc.: Die Aktie (in USD)
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|
Ergebnis je Aktie unverwässert | 3.88 | 5.08 | 4.61 | 5.16 | 5.83 | 5.82 | 5.02 |
Ergebnis je Aktie verwässert | 3.88 | 5.08 | 4.61 | 5.16 | 5.83 | 5.81 | 5.02 |
Dividende pro Aktie | 4.22 | 4.49 | 4.62 | 4.74 | 4.90 | 5.04 | 5.14 |
Gesamtdividendenausschüttung in Mio. | 6’520.00 | 6’885.00 | 7’161.00 | 7’364.00 | 7’580.00 | 7’812.00 | 7’964.00 |
Philip Morris Inc.: Unternehmenskennzahlen (in USD)
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|
Umsatz je Aktie | 18.47 | 19.04 | 19.14 | 18.42 | 20.11 | 20.32 | 22.58 |
KGV (Jahresendkurs, EPS unverwässert) | 27.23 | 13.14 | 18.47 | 16.05 | 16.31 | 17.41 | 18.75 |
KGV (Jahresendkurs, EPS verwässert) | 27.23 | 13.14 | 18.47 | 16.05 | 16.31 | 17.41 | 18.75 |
KGV (Jahresendkurs) | 27.23 | 13.14 | 18.47 | 16.05 | 16.31 | 17.41 | 18.75 |
Dividendenrendite Jahresende in % | 3.99 | 6.73 | 5.43 | 5.73 | 5.16 | 4.98 | 5.46 |
Eigenkapitalquote in % | -23.81 | -26.98 | -22.39 | -23.72 | -19.88 | -10.23 | -14.46 |
Fremdkapitalquote in % | 123.81 | 126.98 | 122.39 | 123.72 | 119.88 | 110.23 | 114.46 |
Philip Morris Inc.: GuV (in Mio. USD)
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|
Umsatzerlöse | 28’688.00 | 29’607.00 | 29’783.00 | 28’697.00 | 31’346.00 | 31’529.00 | 35’060.00 |
Umsatzveränderung in % | 7.35 | 3.20 | 0.59 | -3.65 | 9.23 | 0.58 | 11.20 |
Bruttoergebnis vom Umsatz | 18’167.00 | 18’767.00 | 19’203.00 | 19’048.00 | 21’220.00 | 20’127.00 | 21’761.00 |
Bruttoergebnisveränderung in % | 5.34 | 3.30 | 2.32 | -0.81 | 11.40 | -5.15 | 8.12 |
Operatives Ergebnis | 11’498.00 | 11’374.00 | 11’887.00 | 12’064.00 | 12’972.00 | 12’351.00 | 14’164.00 |
Veränderung Operatives Ergebnis in % | 3.36 | -1.08 | 4.51 | 1.49 | 7.53 | -4.79 | 14.68 |
Ergebnis vor Steuern | 10’589.00 | 10’671.00 | 9’872.00 | 10’953.00 | 12’232.00 | 11’634.00 | 10’450.00 |
Veränderung Ergebnis vor Steuern in % | 6.70 | 0.77 | -7.49 | 10.95 | 11.68 | -4.89 | -10.18 |
Ergebnis nach Steuer | 6’021.00 | 7’895.00 | 7’168.00 | 8’036.00 | 9’083.00 | 9’024.00 | 7’791.00 |
Veränderung Ergebnis nach Steuer in % | -13.34 | 31.12 | -9.21 | 12.11 | 13.03 | -0.65 | -13.66 |
Philip Morris Inc.: Bilanz (in Mio. USD)
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|
Gesamtverbindlichkeiten | 53’198 | 50’540 | 52’474 | 55’446 | 49’498 | 67’992 | 74’750 |
Langzeit Gesamtverbindlichk. pro Aktie | 23.97 | 21.45 | 21.62 | 23.01 | 19.51 | 26.23 | 31.16 |
Eigenkapital | -10’230 | -10’739 | -9’599 | -10’631 | -8’208 | -6’311 | -9’446 |
Veränderung Eigenkapital in % | 4.74 | -3.09 | 7.08 | -8.55 | 19.58 | 11.37 | -25.32 |
Bilanzsumme | 42’968 | 39’801 | 42’875 | 44’815 | 41’290 | 61’681 | 65’304 |
Veränderung Bilanzsumme in % | 16.60 | -7.37 | 7.72 | 4.52 | -7.87 | 49.38 | 5.87 |
Philip Morris Inc.: Sonstige Angaben (in USD)
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|
Gewinn je Aktie (unverwässert) | 3.88 | 5.08 | 4.61 | 5.16 | 5.83 | 5.82 | 5.02 |
Veränderung EPS (unverwässert) in % | -13.39 | 30.93 | -9.26 | 11.97 | 12.96 | -0.14 | -13.77 |
Gewinn je Aktie (verwässert) | 3.88 | 5.08 | 4.61 | 5.16 | 5.83 | 5.81 | 5.02 |
Veränderung EPS (verwässert) in % | -13.39 | 30.93 | -9.32 | 11.97 | 12.96 | -0.20 | -13.72 |
Anzahl Mitarbeiter | 80’600 | 77’400 | 73’500 | 71’000 | 69’600 | 79’800 | 82’700 |
Veränderung Anzahl Mitarbeiter in % | 1.38 | -3.97 | -5.04 | -3.40 | -1.97 | 14.66 | 3.63 |
Philip Morris Inc. Termine
Unternehmen | Event | Datum |
---|---|---|
Philip Morris Inc. | Quartalszahlen | 22.10.24 |
Philip Morris Inc. | Quartalszahlen | 06.02.25 |
Philip Morris Inc. | Quartalszahlen | 17.04.25 |
Philip Morris Inc. | Quartalszahlen | 17.07.25 |
Philip Morris Inc. | Quartalszahlen | 16.10.25 |
Philip Morris Inc. vergangene Termine
Terminart | Info | Datum |
---|---|---|
Quartalszahlen | Q2 2024 Earnings Release | 23.07.24 |
Pressekonferenz | 23.07.24 | |
Pressekonferenz | 23.04.24 | |
Pressekonferenz | 19.10.23 |
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 99.83 |
The Vanguard Group, Inc. | 8.75 |
Vanguard Group, Inc. (Subfiler) | 8.40 |
Capital Research & Management Co. (World Investors) | 7.43 |
Capital Research & Management Co. (International Investors) | 6.75 |
Capital Research & Management Co. (International Investors) | 6.20 |
Capital Research & Management Co. (Global Investors) | 3.85 |
State Street Corp. | 3.50 |
Vanguard Total Stock Market ETF | 3.16 |
BlackRock Fund Advisors | 2.68 |
Vanguard 500 Index Fund | 2.62 |
American Balanced Fund | 2.37 |
GQG Partners LLC | 2.33 |
American Funds Fundamental Investors | 2.21 |
Washington Mutual Investors Fund | 2.14 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 80’600 | 77’400 | 73’500 | 71’000 | 69’600 |
Umsatz pro Mitarbeiter in Mio. EUR | 0.36 | 0.38 | 0.41 | 0.40 | 0.45 |
Bilanz (in Mio. USD) - Aktiva
2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 21’594 | 19’442 | 20’514 | 21’492 | 17’717 |
Summe Anlagevermögen | 22’253 | 19’300 | 20’231 | 19’676 | 18’236 |
Summe Aktiva | 42’968 | 39’801 | 42’875 | 44’815 | 41’290 |
Bilanz (in Mio. USD) - Passiva
2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 34’339 | 31’759 | 31’808 | 32’243 | 28’342 |
Summe Fremdkapital | 53’198 | 50’540 | 52’474 | 55’446 | 49’498 |
Summe Eigenkapital | -10’230 | -10’739 | -9’599 | -10’631 | -8’208 |
Summe Passiva | 42’968 | 39’801 | 42’875 | 44’815 | 41’290 |
Adresse
677 Washington Boulevard, 06901 Stamford | |
Telefon | +1 (203) 905-2410 |
URL | http://www.pmi.com |
Management
Andreas Franz Kurali
Deputy CFO & Head-Finance Transformation |
André Calantzopoulos
Executive Chairman |
Ankur Modi
Global Head-Strategy & Program Delivery |
Badrul A. Chowdhury
Chief Life Sciences Officer |
Brant Bonin Bough
Independent Director |
Darlene Quashie Henry
Secretary, VP & Associate General Counsel |
Deepak Mishra
President-Americas Region |
Dessislava Temperley
Independent Non-Executive Director |
Emmanuel Andre Marie Babeau
Chief Financial Officer |
Frank de Rooij
Vice President-Treasury & Corporate Finance |
Frederic Patitucci
Chief People & Culture Officer |
Frederic de Wilde
President-South & Southeast Asia |
Jacek Olczak
Chief Executive Officer & Director |
James Bushnell
VP-Investor Relations & Financial Communications |
Jennifer Motles
Chief Sustainability Officer |
Jorge Insuasty
President-Vectura Fertin Pharma |
Juan José Daboub
Independent Director |
Kalpana Jaisingh Morparia
Independent Director |
Keagen Lenihan
Vice President-Government Affairs & Public Policy |
Khang Wei Lim
Director-Internal Control Asia |
Laurent Boissart
President-Japan |
Lisa A. Hook
Lead Independent Director |
Marco Mariotti
President-Eastern Europe Region |
Marian Salzman
Chief Corporate Citizenship Officer & SVP |
Massimo Andolina
President-Europe Region |
Matthew Holman
VP-US Scientific Engagement & Regulatory Strategy |
Michael Voegele
Chief Digital & Information Officer |
Michel Combes
Independent Director |
Moira Gilchrist
Chief Communications Officer |
Pattaraporn Auttaphon
Controller-South & South East Asia |
Reginaldo Dobrowolski
Vice President & Controller |
Reinhard Kraxner
Assistant General Counsel |
Reza Shahrbabaki
Vice President |
Robert B. Polet
Independent Director |
Scott Coutts
Senior Vice President-Operations |
Shlomo Yanai
Independent Director |
Silke Muenster
Chief Diversity Officer |
Stacey Kennedy
President-South & Southeast Asia Region |
Stefano Volpetti
Chief Consumer Officer |
Victoria Dux Harker
Independent Director |
Waynn Wu
Chief Strategy Officer |
Werner Barth
President-Combustibles Category |
Werner Geissler
Independent Director |
Yann Guerin
Senior Vice President & General Counsel |